Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Fortress Biotech (FBIO) Change in Inventory: 2016-2024

Historic Change in Inventory for Fortress Biotech (FBIO) over the last 9 years, with Dec 2024 value amounting to $4.2 million.

  • Fortress Biotech's Change in Inventory fell 149.21% to -$1.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30,000, marking a year-over-year decrease of 96.07%. This contributed to the annual value of $4.2 million for FY2024, which is 206.88% up from last year.
  • Fortress Biotech's Change in Inventory amounted to $4.2 million in FY2024, which was up 206.88% from -$4.0 million recorded in FY2023.
  • Over the past 5 years, Fortress Biotech's Change in Inventory peaked at $8.5 million during FY2021, and registered a low of -$4.0 million during FY2023.
  • In the last 3 years, Fortress Biotech's Change in Inventory had a median value of -$1.7 million in 2022 and averaged -$490,667.
  • As far as peak fluctuations go, Fortress Biotech's Change in Inventory soared by 1,446.25% in 2021, and later plummeted by 126.66% in 2023.
  • Fortress Biotech's Change in Inventory (Yearly) stood at $547,000 in 2020, then spiked by 1,446.25% to $8.5 million in 2021, then crashed by 120.62% to -$1.7 million in 2022, then tumbled by 126.66% to -$4.0 million in 2023, then surged by 206.88% to $4.2 million in 2024.